19.12.2018 Symrise AG  DE000SYM9999

DGAP-News: Symrise Executive Board members Heinrich Schaper and Jean-Yves Parisot early confirmed in office


 

DGAP-News: Symrise AG / Key word(s): Change of Personnel/Contract
Symrise Executive Board members Heinrich Schaper and Jean-Yves Parisot early confirmed in office

19.12.2018 / 10:00
The issuer is solely responsible for the content of this announcement.


The Supervisory Board of Symrise AG confirmed in advance the extension of the contracts of Executive Board members Heinrich Schaper and Dr. Jean-Yves Parisot. Both executives have been part of the management committee since 2016. The Supervisory Board thereby acknowledges the major contribution made by the two managers to the sustainable expansion of the operations of the Symrise segments Flavor and Nutrition, and the strategic alignment of the businesses to customer needs.
 

The contract of Flavor Board member Heinrich Schaper (62) is being extended in advance to 2022. Heinrich Schaper has been working for Symrise AG and its predecessor company for more than four decades now. Since 2016, he has been President of the Flavor segment. Heinrich Schaper has comprehensive experience in leading roles and has held positions in Germany and abroad. He has furthermore held various management functions in the United States and in the EAME region (Europe, Africa, Middle East). After obtaining a degree in Marketing and Industrial Management, he started his professional career as a Sales Manager for Flavors in 1978.
 

The contract of Nutrition Board member Dr. Jean-Yves Parisot (54) is being extended in advance until 2024. Since 2016, Jean-Yves Parisot has headed the Nutrition Segment that emerged from the takeover of the Diana Group in 2014. Prior to the acquisition and integration of Diana within Symrise AG, he headed the Food Division in the Diana Group for five years. He had previously worked in leading positions with several global chemicals, pharmaceuticals, and biotech companies, including at Air Liquide, Danisco and Rhodia. He started his career in Sales & Marketing at Pfizer. Jean-Yves Parisot studied Veterinary Medicine and has an MBA degree from HEC Paris.
 

Dr. Thomas Rabe, Chairman of the Supervisory Board of Symrise AG, said: "Our management team has two extraordinarily experienced and distinguished managers in Heinrich Schaper and Jean-Yves Parisot. We are therefore delighted to be able to provide advance confirmation of their positions. The continuous and dynamic development of the business has thereby been secured for the employees, customers and shareholders of Symrise."

 

 

About Symrise:

Symrise is a global supplier of fragrances, flavors, food and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food.

Its sales of EUR 3 billion in the 2017 fiscal year make Symrise a leading global provider in the flavor, nutrition and fragrance markets. Headquartered in Holzminden, Germany, the Group is represented by around 100 sites in Europe, Africa, the Middle East, Asia, the United States and Latin America.

Symrise works with its clients to develop new ideas and market-ready concepts for products that form an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more.

www.symrise.com

 

Media Contact: Investor Contact:
Bernhard Kott Tobias Erfurth
Tel.: +49 (0)5531 90-1721 Tel.: +49 (0)5531 90-1879
Email: [email protected] Email: [email protected]
 

 

Social media:

twitter.com/symriseag
linkedin.com/company/symrise
youtube.com/agsymrise
xing.com/companies/symrise

 



19.12.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: [email protected]
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

754935  19.12.2018 

fncls.ssp?fn=show_t_gif&application_id=754935&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.996,29 3.154,03 3.407,85 3.520,45 3.825,69 4.618,48 4.730,19
EBITDA1,2 630,31 630,52 685,07 742,08 813,62 795,42 851,65
EBITDA-Marge3 21,04 19,99 20,10 21,08 21,27 17,22
EBIT1,4 431,59 433,97 455,35 487,51 558,96 503,98 559,36
EBIT-Marge5 14,40 13,76 13,36 13,85 14,61 10,91 11,83
Jahresüberschuss1 275,65 297,69 297,88 314,95 385,03 290,70 344,94
Netto-Marge6 9,20 9,44 8,74 8,95 10,06 6,29 7,29
Cashflow1,7 396,18 441,79 546,76 635,68 521,56 360,11 719,51
Ergebnis je Aktie8 2,06 2,08 2,12 2,22 2,70 2,00 2,44
Dividende8 0,88 0,90 0,95 0,97 1,02 1,10 0,85
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

INVESTOR-INFORMATIONEN
©boersengefluester.de
Symrise
WKN Kurs in € Einschätzung Börsenwert in Mio. €
SYM999 99,920 Halten 13.966,02
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
29,39 38,24 0,80 44,63
KBV KCV KUV EV/EBITDA
4,02 19,41 2,95 19,53
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,10 1,10 1,10 15.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 01.08.2024 24.10.2024 06.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-2,71% 2,29% 0,28% -7,65%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Symrise AG  ISIN: DE000SYM9999 können Sie bei EQS abrufen


Chemie , SYM999 , SY1 , XETR:SY1